Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion for Postoperative Cognitive Function in Elderly Orthopedic Patients
NCT01179100Phase 4Withdrawn
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Jun 2011
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in Post-operative cognitive dysfunction (POCD), postoperative delirium (POD), postoperative pain, sponsored by Cedars-Sinai Medical Center. Planned start Jun 2011; status: withdrawn.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative delirium (POD)postoperative pain
Beyond the preview
Go deeper on NCT01179100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179100.